A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults
收藏DataCite Commons2025-11-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011810/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of HIV-1 envelope protein BG505 SOSIP.GT1.1 gp140 trimer Vaccine, Adjuvanted, in up to 48 healthy HIV-uninfected adult volunteers.
提供机构：
Vivli
创建时间：
2025-10-01
